FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 60 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $1,049,000 | -47.0% | 345,100 | -58.5% | 0.00% | -33.3% |
Q2 2019 | $1,980,000 | -24.1% | 832,025 | +19.6% | 0.00% | -25.0% |
Q1 2019 | $2,608,000 | -31.0% | 695,489 | -33.9% | 0.00% | -33.3% |
Q4 2018 | $3,779,000 | -42.8% | 1,052,741 | -8.7% | 0.01% | -25.0% |
Q3 2018 | $6,607,000 | +294.4% | 1,153,128 | +244.8% | 0.01% | +300.0% |
Q2 2018 | $1,675,000 | -57.2% | 334,417 | -56.2% | 0.00% | -60.0% |
Q1 2018 | $3,916,000 | -12.4% | 763,296 | +2.6% | 0.01% | -16.7% |
Q4 2017 | $4,469,000 | +13.5% | 743,668 | +4.8% | 0.01% | 0.0% |
Q3 2017 | $3,939,000 | +589.8% | 709,775 | +476.7% | 0.01% | +500.0% |
Q2 2017 | $571,000 | -54.5% | 123,085 | -51.4% | 0.00% | -50.0% |
Q1 2017 | $1,254,000 | -59.6% | 253,384 | -9.3% | 0.00% | -66.7% |
Q4 2016 | $3,101,000 | +344.3% | 279,391 | +270.9% | 0.01% | +500.0% |
Q3 2016 | $698,000 | -44.3% | 75,337 | -61.9% | 0.00% | -66.7% |
Q2 2016 | $1,254,000 | +67.9% | 197,508 | +72.4% | 0.00% | +50.0% |
Q1 2016 | $747,000 | -18.1% | 114,574 | +1.9% | 0.00% | 0.0% |
Q4 2015 | $912,000 | -21.4% | 112,427 | -29.0% | 0.00% | 0.0% |
Q3 2015 | $1,161,000 | +320.7% | 158,397 | +489.3% | 0.00% | +100.0% |
Q2 2015 | $276,000 | -47.5% | 26,879 | -52.8% | 0.00% | 0.0% |
Q1 2015 | $526,000 | +179.8% | 56,900 | +64.8% | 0.00% | – |
Q3 2014 | $188,000 | – | 34,533 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
NATIONS FINANCIAL GROUP INC, /IA/ /ADV | 20,150 | $0 | 0.00% |
Advisory Services Network, LLC | 2,233 | $0 | 0.00% |
Fernwood Investment Management, LLC | 34,000 | $0 | 0.00% |